function
antagonist of PrkC-dependent phosphorylation
product
protein phosphatase
Genomic Context
categories
[category|SW 3|Information processing] → [category|SW 3.3|Protein synthesis, modification and degradation] → [category|SW 3.3.4|Protein modification] → [category|SW 3.3.4.4|Protein phosphatases]Gene
Coordinates
1,650,384 → 1,651,148
Phenotypes of a mutant
A ''prpC'' mutant is less lytic in late stationary phase. [Pubmed|12399479]inactivation of ''[gene|84447F9A6644EA8A7593BB99B2B69D4377E670E2|prpC]'' reduces sporulation efficiency to 50.7% that of wild type cells [Pubmed|26735940]The protein
Catalyzed reaction/ biological activity
dephosphorylation of [gene|E771685D6D41D48E0C0AF77F15B4F380820FCDC2|EF-tu]]]-Thr63-P [Pubmed|26056311][SW|Cofactors]
divalent cations such as magnesium or manganeseEffectors of protein activity
inhibited by inorganic phosphate and glycero-2-phosphate [Pubmed|16857667]Structure
[PDB|1TXO] (from ''Mycobacterium tuberculosis'', 34% identity, 54% similarity) [Pubmed|15530359]Expression and Regulation
Operons
genes
[gene|84447F9A6644EA8A7593BB99B2B69D4377E670E2|prpC]-[gene|23FF4A00C36EC1B7297F51A9EF3579B41F0B7EBA|prkC]-[gene|519D4694B2895EE6F0D38D918F52F27734506848|cpgA]-[gene|8103B8539338B77CF51B16B7FA76783ED2319F13|rpe]-[gene|0ACE023DCD6A6BB5A1827D1D997BDFAC3B168C51|yloS]
description
[Pubmed|22383849]
view in new tabBiological materials
Mutant
MGNA-B133 (yloO::erm), available at the [https://shigen.nig.ac.jp/bsub/resource/strainGeneDisrupted/detail/1132 NBRP B. subtilis, Japan]OMG401 (aphA3), available in the [SW|Stülke] lab1A962 (no resistance), [Pubmed|12399479], available at [http://pasture.asc.ohio-state.edu/BGSC/getdetail.cfm?bgscid=1A962&Search=1A962 BGSC]1A964 (no resistance), [Pubmed|12399479], available at [http://pasture.asc.ohio-state.edu/BGSC/getdetail.cfm?bgscid=1A964&Search=1A964 BGSC]References
Reviews
Original publications
19246764,10986276,17693724,12399479,18757537,15530359,23793375,16025310,24390483,25012659,26056311,26735940,27806131